Bank of Montreal closed 3.5% short of its 52-week high of C$147.54, which the company achieved on December 6th.

BMO Capital Markets maintained its Outperform rating and $545.00 price target on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), representing a 16% upside from the current price of $469.97. With a ...

Bank of Montreal closed 3.6% short of its 52-week high of C$147.54, which the company reached on December 6th.

February 11, 2025, 03:39 AM ET, BY Momei, Contributor, Stock Traders Daily | Editor: Derek Curry ( Follow on LinkedIn ) ...

BMO SPDR Utilities Select Sector Index ETF (TSX: ZXLU) (TSX: ZXLU.F) ...

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond ...

Despite its mixed financial performance in recent quarters, BMO’s consistent focus on long-term growth initiatives and U.S.

Overview: Bank of Montreal offers diversified financial services primarily in North America and has a market capitalization of approximately CA$102.66 billion. Operations: Bank of Montreal's ...

Bank of Montreal (BMO) announced that it has received approvals from the Toronto Stock Exchange and the Office of the Superintendent of Financial Institutions Canada to proceed with its previously ...

TD stock looks like a great value stock to buy now. Although Bank of Montreal (TSX:BMO) stock rose about 6% last year, it still underperformed the broader market by a wide margin as the TSX ...

The products are subject to final approval by Cboe Canada. Once they are listed on the exchange, BMO will become the second ...